Evaluasi Adverse Drug Reactions (ADRs) Penyakit Kanker Payudara Dengan Kemoterapi Berbasis Antrasiklin Di RSUD Prof. Dr. Margono Soekardjo Purwokerto
Abstract
ABSTRAK Kanker payudara merupakan salah satu kanker dengan insidensi terbanyak padawanita. Salah satuterapi yang diberikan pada pasien kanker payudara adalah regimen berbasis antrasiklin. Penggunaan obat meningkatkan kemungkinan terjadinya Adverse Drug Reactions (ADRs) yang dapat membahayakan kesehatan dan kehidupan pasien. Penelitian ini merupakan penelitian observasional deskriptif analitik dengan metode pengambilan data secara prospektif. Data yang dikumpulkan berupa wawancara dengan skala naranjo. Sampel yang digunakan sebanyak 46 responden. Kejadian adverse drug reaction terbanyak yang terjadi adalah mual (89,15%), muntah (82,6%), alopecia (76.08%), anoreksia (71,74%), lemas (60,87%), diare (45,65%), dehidrasi (34,77%), demam (39,13%), insomnia (32,6%), sariawan (21,74%), dan anemia (13,04%). Berdasarkan hasil penelitian, adverse drug reactions yang paling sering terjadi pada pasien kanker payudara dengan kemoterapi berbasis antrasiklin adalah mual. Kata kunci: mual, kemoterapi berbasis antrasiklin, skala naranjo. ABSTRACT Breast cancer is one of the most type of cancer with highest incidence in women. one of therapy in breast cancer is anthracycline-based chemotherapy. Drugs uses increases occurance of adverse drug reactions (ADRs) that may lead endanger the health and life patients. This research is a descriptive and analytical observational research with prospective data collection methods. Data collected by interview with naranjo scale. There were 46 patients included as samples of this research. The most frequently adverse drug reactions was nausea (89.15%), vomiting (82.6%), alopecia (76.08%), anorexia (71.74%), fatigue (60.87%), diarhea (45.65%), fever (39.13%), dehydration (34.77%), sleep disorder (32.6%), oral ulceration (21.74%), and anemia (13.04%). Based on the research, the most frequently adverse drug reactions of anthracycline-based chemotherapy in patient with breast cancer was nausea. Key words: anthracycline-based chemotherapy, naranjo scale, nausea.References
Ancoli, S., Liu, L., Marler, M.R., Parker, B.A., Jones, V., Sadler, G.R., Dimsdale, J., Cohen-Zion, M., Fiorentino, L. 2006. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer, 14(3):201-209. Beers, M.H. dan Berko, R. 1999. The merk manual. 17th ed. USA. pp. 990-993. Brighton, D., dan Wood, M. (eds). 2005. The royal marsden hospital handbook of cancer chemotherapy a guide for the multidisciplinary team. Churchill Livingstone: Elsevier. pp. 273-291. Chan, V.T. dan Yeo, W. 2011. Antiemetic therapy options for chemotherapy-induced nausea and vomitting in breast cancer patient. Breast Cancer: Targets and Therapy, 3:151-160. Classen, D.C., Pestotnik, S.L., Evans, R.S., Lioyd, J.F. dan Burke, J.P. 1997. Adverse drug events in hospitalized patients, Excess length of stay, extra costs, and attributable mortality. JAMA, 277:301-6 Dahlan, S.M., 2010, Besar Sampel Penelitian Kedokteran dan Kesehatan. Seri ke-3. Jakarta: Salemba Medika. Dipiro, J.T., Talbert, R.L., Yee, G.C., Matzke, G.R., Wells, B.G., Posey, L.M. 2008. Pharmacotherapy a pathophysiologic approach. 7th Edition. New York: McGraw Hill Medical. pp. 2085-2156. Doherty, M.J. 2009. Algorithms for assessing the probability of an Adverse drug reaction. Respiratory Medicine CME, 2(2):63-67. Giordano, F.K. dan Jatoi, A. 2005. A synopsis of cancer-related anorexia and weight loss. US Oncology Review, 1(1):1-5. Groopman, E.J., Loretta, M.I. 1999. Chmeotherapy induced anemia in adults: incidence and treatment. J Natl Cancer Inst, 91: 1616-1634. Gunawan, S.G., Nafriald, R.S., Elysabeth (eds). 2007, Farmakologi dan terapi. Edisi 5. Jakarta: Departemen Farmakologi dan Therapeutik FK-UI. Hall, J. dan Guyton, A. 1997. Buku ajar fisiologi kedokteran. Setiawan, I., penerjemah. Terjemahan dari: Textbook of medical physiology Jakarta: Penerbit Buku Kedokteran EGC. Hillarius, D., Kloeg, P., Wall, E., Heuvel, J., Gundy, C., Aaronson, N. 2012. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer, 20:107-117. Jose, J. dan Rao, P.G. 2006. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital. Pharmacol Res, 54: 226-233. Lazarou, J., Pomeranz, B.H., Corey, P.N. 1998. Incidence of adverse drug reactions in hospitalized patients. JAMA, 279(15):1200-1205. National Hospital Morbidity Data Collections. 1993. Australia. Sweetman, S.C. 2002. In: Martindale: the complete drug reference. 33rd ed. London: Pharmaceutical Press. pp 645.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
